Epidermolysis bullosa. II. Type VII collagen mutations and phenotype-genotype correlations in the dystrophic subtypes
about
Inherited epidermolysis bullosaLysyl Hydroxylase 3 Localizes to Epidermal Basement Membrane and Is Reduced in Patients with Recessive Dystrophic Epidermolysis BullosaTwo novel mutations on exon 8 and intron 65 of COL7A1 gene in two Chinese brothers result in recessive dystrophic epidermolysis bullosaLow-level laser therapy for the treatment of epidermolysis bullosa: a case report.Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa.Induced pluripotent stem cells from individuals with recessive dystrophic epidermolysis bullosa.Rat model for dominant dystrophic epidermolysis bullosa: glycine substitution reduces collagen VII stability and shows gene-dosage effectPregnancy after PGD for recessive dystrophic epidermolysis bullosa inversa: genetics and preimplantation genetics.Photodynamic therapy for Basal cell carcinoma in recessive dystrophic epidermolysis bullosaLosartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanismsBicodon bias can determine the role of synonymous SNPs in human diseases.A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy.Anchorless keratinocyte survival: an emerging pathogenic mechanism for squamous cell carcinoma in recessive dystrophic epidermolysis bullosa.Common interruptions in the repeating tripeptide sequence of non-fibrillar collagens: sequence analysis and structural studies on triple-helix peptide models.Oral manifestations in the epidermolysis bullosa spectrum.Keratinocyte-/fibroblast-targeted rescue of Col7a1-disrupted mice and generation of an exact dystrophic epidermolysis bullosa model using a human COL7A1 mutation.Fluorescent protein markers to tag collagenous proteins: the paradigm of procollagen VII.Epidermolysis bullosa with pyloric atresia.Type VII collagen: the anchoring fibril protein at fault in dystrophic epidermolysis bullosa.Treatment of hereditary epidermolysis bullosa: updates and future prospects.Inherited blistering skin diseases: underlying molecular mechanisms and emerging therapies.Proteases and proteomics: cutting to the core of human skin pathologies.Epidermolysis bullosa in animals: a review.Recessive dystrophic epidermolysis bullosa: a review of disease pathogenesis and update on future therapies.A novel deletion and two recurrent substitutions on type VII collagen gene in seven Iranian patients with epidermolysis bullosa.Intraepidermal Type VII Collagen by Immunofluorescence Mapping: A Specific Finding for Bullous Dermolysis of the Newborn.Characterization of molecular mechanisms underlying mutations in dystrophic epidermolysis bullosa using site-directed mutagenesis.Transient bullous dermolysis of the newborn: a novel de novo mutation in the COL7A1 gene.Type VII collagen gene mutations (c.8569G>T and c.4879G>A) result in the moderately severe phenotype of recessive dystrophic epidermolysis bullosa in a Korean patient.SIN retroviral vectors expressing COL7A1 under human promoters for ex vivo gene therapy of recessive dystrophic epidermolysis bullosa.Collagen VII plays a dual role in wound healing.Protein therapeutics for junctional epidermolysis bullosa: incorporation of recombinant beta3 chain into laminin 332 in beta3-/- keratinocytes in vitro.The international dystrophic epidermolysis bullosa patient registry: an online database of dystrophic epidermolysis bullosa patients and their COL7A1 mutations.Remodeling of the dermal-epidermal junction in bilayered skin constructs after silencing the expression of the p.R2622Q and p.G2623C collagen VII mutants.Increased invasive behaviour in cutaneous squamous cell carcinoma with loss of basement-membrane type VII collagen.Novel deletion mutation (c.3717del5) in COL7A1 in a patient with recessive dystrophic epidermolysis bullosa.Vascular access for chronic hemodialysis in a patient with epidermolysis bullosa dystrophica Hallopeau-Siemens.Compound heterozygosity of the novel -186C>T mutation in the COL7A1 promoter and the recurrent c.497insA mutation leads to generalized dystrophic epidermolysis bullosa.Congenital dystrophic epidermolysis bullosa (DEB) in Sprague Dawley rats: a case series.A comprehensive next-generation sequencing assay for the diagnosis of epidermolysis bullosa.
P2860
Q21202884-30C9B7AB-AF3C-4DF2-9F93-5577B89397F5Q27318540-53DDFFED-2677-43FA-BDD8-19A25AB210C0Q28485440-E47BFC5F-D8D3-4CD7-9730-0E532C28FF99Q33632513-923E0AF6-9FE0-4AE8-8AA3-FD4186F6F4CAQ33712943-797AE2D5-B79C-488C-A1BB-893FF2468EFEQ34120479-73001B4A-19D2-4D4C-86D9-6B923F7A0F59Q34745503-E8E80027-7B4B-4BCD-AABD-FEC7D7451A5EQ35204461-5D846AAF-0D89-4BA2-9EE1-66E067B85819Q35684352-9C90A067-1B21-4A91-8A73-E13BEE289178Q36057596-ED3613C7-77EA-4203-AC4F-F4D7563A5C81Q36306493-39F07842-5456-4549-891D-85324A82D0C5Q36512219-8D01707E-DEA1-4777-8345-D59EE6645EEEQ36828939-EC9C4A55-99D3-49DD-AE07-46E53FC6D255Q37335428-7644F05D-0B65-4E5B-95A0-037172F8A3F8Q37454829-19F40690-4316-4981-8417-234760ABEFEAQ37462643-24CA0667-3F3A-449D-9A68-E525405BA466Q37484666-59A5E6DF-EE16-40CF-AF2E-347B92433A4AQ37640758-5F8AA32C-BCA4-4708-AFFF-C2AE1890EF6BQ37640771-61AEB4AB-BA46-43DE-BF7C-AC47F16587B7Q38176832-CB64D483-24CF-4C1D-ACF3-AEAD8D777ACBQ38180485-04C28C90-4CBE-4E32-9818-2375727B714CQ38200069-F1297A8B-5C4C-47F9-A010-A56E94E1ACB7Q38263696-EC5FBEFD-6427-409A-9153-89417C4A3F33Q38510204-6ECE582E-1A89-46CB-8059-B198353E452CQ38811015-E6FDAB5F-DB46-48B8-80ED-C9C3D303DA44Q39317520-C2C8A8AA-1E4E-4E81-BFCA-9F37BA54591EQ39599980-131B6030-9B2A-40AF-96EE-58EA18464AD6Q41176379-29418EF3-496F-4825-AA91-6C5806528E88Q41781303-DE2F1221-A81C-44E5-94C7-B667D3EB5123Q41811020-A25B7BEE-7297-43AA-A2E3-BDADEBBE721EQ41843053-EC2C93AC-BB21-44DE-90C0-A0FE90E57903Q42175704-5148D8C7-61F8-4131-9C4F-9A25D296ED5CQ42605404-AB566257-2BED-4A43-8690-7298380DF29BQ43042273-437079A4-CC8F-47E1-B2A8-C1FE46AC4224Q43124292-E19EE6CB-E936-488A-B721-818A6A5BFC98Q43832938-BF24CB28-E8B5-4B11-B6C6-3836CB892A29Q43852874-9B629DC2-1809-4190-8502-05355123DA66Q44500682-85599A2C-A974-43CD-912B-7390696266EEQ45028248-721929D4-9DED-44BE-9F01-E122700EFDC4Q48244290-732B869E-1A21-4852-AAAF-45BE4E101C6F
P2860
Epidermolysis bullosa. II. Type VII collagen mutations and phenotype-genotype correlations in the dystrophic subtypes
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Epidermolysis bullosa. II. Typ ...... ons in the dystrophic subtypes
@ast
Epidermolysis bullosa. II. Typ ...... ons in the dystrophic subtypes
@en
Epidermolysis bullosa. II. Typ ...... ons in the dystrophic subtypes
@nl
type
label
Epidermolysis bullosa. II. Typ ...... ons in the dystrophic subtypes
@ast
Epidermolysis bullosa. II. Typ ...... ons in the dystrophic subtypes
@en
Epidermolysis bullosa. II. Typ ...... ons in the dystrophic subtypes
@nl
prefLabel
Epidermolysis bullosa. II. Typ ...... ons in the dystrophic subtypes
@ast
Epidermolysis bullosa. II. Typ ...... ons in the dystrophic subtypes
@en
Epidermolysis bullosa. II. Typ ...... ons in the dystrophic subtypes
@nl
P2093
P2860
P356
P1476
Epidermolysis bullosa. II. Typ ...... ons in the dystrophic subtypes
@en
P2093
Ellen Pfendner
Roslyn Varki
Sara Sadowski
P2860
P304
P356
10.1136/JMG.2006.045302
P407
P50
P577
2007-03-01T00:00:00Z